Genes and environment in irritable bowel syndrome: One step forward

Gut

Volumn 55, Issue 12, 2006, Pages 1694-1696

  Talley, N J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; SEROTONIN; SEROTONIN TRANSPORTER;

BIRTH WEIGHT; CAMPYLOBACTER JEJUNI; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC REGULATION; GENETIC VARIABILITY; HEREDITY; HUMAN; INFLAMMATION; IRRITABLE COLON; NOTE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SOCIAL PSYCHOLOGY;

BACTERIAL INFECTIONS; ENVIRONMENTAL EXPOSURE; GASTROENTERITIS; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INTERLEUKIN-10; IRRITABLE BOWEL SYNDROME; RISK FACTORS; SEROTONIN; TWINS;

EID: 33845421679     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.108837     Document Type: Note

References (37)

1. Talley N, Spiller RC. Irritable bowel syndrome: A little understood organic bowel disease? Lancet 2002;360:555-64.
2. Drossman D, Camilleri M, Mayer E, et al. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108-31.
3. Locke GR III, Zinsmeister AR, Talley NJ, et al. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 2000;75:907-12.
4. Kalantar JS, Locke GR III, Zinsmeister AR, et al. Familial aggregation of irritable bowel syndrome: a prospective study. Gut 2003;52:1703-7.
5. Saito YA, Petersen GM, Locke GRI, Talley NJ. The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol 2005;3:1057-65.
6. Morris-Yates A, Talley NJ, Boyce PM, et al. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol 1998;93:1311-17.
7. Levy RL, Jones KR, Whitehead WE, et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology 2001;121:799-804.
8. Mohammed I, Cherkas LF, Riley SA, et al. Genetic influences in irritable bowel syndrome: A twin study. Am J Gastroenterol 2005;100:1340-4.
9. Bengtson MB, Ronning T, Vatn MH, et al. IBS in twins: genes and environment. Gut 2006;55:000-0.
10. Holtmann G, Talley NJ. Hypothesis driven research and molecular mechanisms in functional dyspepsia: the beginning of a beautiful friendship in research and practice? Am J Gastroenterol 2006;101:593-5.
11. Gonsalkorale WM, Perrey C, Pravica V, et al. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut 2003;52:91-3.
12. van der Veek P, van den Berg M, de Kroon YE, et al. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome. Am J Gastroenterol 2005;100:2510-16.
13. Pata C, Erdal ME, Derici E, et al. Serotonin transporter gene polymorphism in irritable bowel syndrome. Am J Gastroenterol 2002;97:1780-4.
14. Kim HJ, Camilleri M, Carlson PJ, et al. Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 2004;53:829-37.
15. Yeo A, Boyd P, Lumsden S, et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 2004;53:1452-8.
16. Holtmann G, Siffert W, Haag S, et al. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology 2004;126:971-9.
17. Andresen V, Camilleri M, Kim HJ, et al. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology 2006;130:1985-94.
18. 2A receptor gene with irritable bowel syndrome 5-Ht2A gene polymorphism in irritable bowel syndrome. J Clin Gastroenterol 2004;38:561-6.
19. Saito YA, Cremonini F, Talley NJ. Association of the 1438G/A and 102T/C polymorphism of the 5-HT2A receptor gene with irritable bowel syndrome 5-HT2A gene polymorphism in irritable bowel syndrome. J Clin Gastroenterol 2005;39:835.
20. Locke GR III, Ackerman MJ, Zinsmeister AR, et al. Gastrointestinal symptoms in families of patients with an SCN5A-encoded cardiac channelopathy: evidence of an intestinal channelopathy. Am J Gastroenterol 2006;101:1299-304.
21. Caspi A, Moffitt TE. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 2006;7:583-90.
22. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003;361:598-604.
23. Lin BK, Clyne M, Walsh M, et al. Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. Am J Epidemiol 2006;164:1-4.
24. Locke GR III, Zinsmeister AR, Talley NJ, et al. Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol 2000;95:157-65.
25. Howell S, Talley NJ, Quine S, et al. The irritable bowel syndrome has origins in the childhood socioeconomic environment. Am J Gastroenterol 2004;99:1572-8.
26. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-6.
27. Marshall JK, Thabane M, Garg AX, et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006;131:445-50.
28. Dunlop SP, Jenkins D, Neal KR, et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003;125:1651-9.
29. Maes M, Bonaccorso S, Marino V, et al. Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation. Mol Psychiatry 2001;6:475-80.
30. Talley NJ, Boyce PM, Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study. Gut 1998;42:47-53.
31. Koloski NA, Talley NJ, Boyce PM. A history of abuse in community subjects with irritable bowel syndrome and functional dyspepsia: the role of other psychosocial variables. Digestion 2005;72:86-96.
32. Atkinson W, Sheldon TA, Shaath N, et al. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut 2004;53:1459-64.
33. Coutinho SV, Plotsky PM, Sablad M, et al. Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am J Physiol Gastrointest Liver Physiol 2002;282:G307-16.
34. Morley R. Fetal origins of adult disease. Semin Fetal Neonatal Med 2006;11:73-8.
35. Eslick GD, Yan P, Xia HH, et al. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther 2002;16:1677-82.
36. Whitcomb DC, Aoun E, Vodovotz Y, et al. Evaluating disorders with a complex genetics basis: the future roles of meta-analysis and systems biology. Dig Dis Sci 2005;50:2195-202.
37. Naliboff BD, Berman S, Suyenobu B, et al. Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients. Gastroenterology 2006;131:352-65.